Marc A. Webster
AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 10, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.
Journal: Current oncology (Toronto, Ont.)
Published: January 28, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).
Journal: Current oncology (Toronto, Ont.)
Published: January 16, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.
Journal: Current oncology (Toronto, Ont.)
Published: December 24, 2025
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.
Journal: Current oncology (Toronto, Ont.)
Published: December 07, 2025
Clinician's guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer.
Journal: Therapeutic advances in medical oncology
Published: November 27, 2024
Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study.
Journal: The Lancet. Oncology
Published: October 14, 2024
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting.
Journal: Current oncology (Toronto, Ont.)
Published: September 20, 2024
Nighttime compression supports improved self-management of breast cancer-related lymphedema: A multicenter randomized controlled trial.
Journal: Cancer
Published: April 05, 2021
Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 16, 2016
A systematic comparison of three commercial estrogen receptor assays in a single clinical outcome breast cancer cohort.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 13, 2016
Last Updated: 09/26/2026